"If you ve possibly been exposed to the coronavirus (COVID-19) and are experiencing symptoms, we recommend that your first contact with a health care provider be through telemedicine. Houston Methodist Virtual Urgent Care is available 24/7- no appointment necessary. Or, if you re planning an in-person visit, please call ahead to inform your healthcare provider."

During the past decade, Methodist Willowbrook Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 8 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Methodist Willowbrook Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "The Methodist Hospital Research Institute" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "GOG Foundation" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Methodist Willowbrook Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Methodist Willowbrook Hospital" are "Ovarian Seromucinous Carcinoma" (6 trials), "Breast Cancer" (5 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (4 trials), "Fallopian Tube Transitional Cell Carcinoma" (4 trials) and "Ovarian Clear Cell Adenocarcinoma" (4 trials). Many other conditions were trialed in "Methodist Willowbrook Hospital" in a lesser frequency.

Most popular intervention types in "Methodist Willowbrook Hospital" are "Drug" (25 trials), "Other" (21 trials), "Biological" (13 trials), "Procedure" (10 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Quality-of-Life Assessment" (11 trials), "Paclitaxel" (10 trials), "Questionnaire Administration" (9 trials) and "Carboplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Methodist Willowbrook Hospital" are 18 trials for "Female" genders and 12 trials for "All" genders.

Currently, there are NaN active trials in "Methodist Willowbrook Hospital". undefined are not yet recruiting, 9 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Methodist Willowbrook Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Methodist Willowbrook Hospital, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".